The prevalence of hepatitis C virus in mashhad, iran: a population-based study

Mohammad Taghi Shakeri1, Hosein Nomani, Majid Ghayour Mobarhan

  • 1Department of Biostatistics, Public Health School, Mashhad University of Medical Sciences, Mashhad, IR Iran.

Hepatitis Monthly
|June 8, 2013
PubMed

Insights

Hepatitis C virus (HCV) infection prevalence is less than 1% in Mashhad, Iran. This study assessed HCV seropositivity in the general population using ELISA and RT-PCR methods.

Area of Science:

  • Epidemiology
  • Virology
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection poses a global health challenge, with chronic infections leading to severe liver disease, cirrhosis, and hepatocellular carcinoma.
  • The absence of an HCV vaccine necessitates effective control measures, highlighting the importance of epidemiological studies for disease management.
  • Understanding HCV's spread is crucial for community-level interventions and monitoring infection rates.

Purpose of the Study:

  • To determine the prevalence of hepatitis C seropositivity in the general population of Mashhad, located in northeast Iran.
  • To provide essential data for public health strategies aimed at controlling HCV transmission in the region.

Main Methods:

  • A cluster sampling method was employed to recruit 3870 individuals from the general population of Mashhad.
  • Hepatitis C virus (HCV) seropositivity was initially assessed using an HCV antibody detection ELISA kit.
  • Results from ELISA were confirmed using the more sensitive reverse transcriptase polymerase chain reaction (RT-PCR) method to accurately determine HCV infection prevalence.

Main Results:

  • The overall seroprevalence of hepatitis C, detected by ELISA, was found to be 0.2%.
  • Confirmation using RT-PCR revealed a lower overall prevalence of Hepatitis C virus infection at 0.13%.
  • Both methods indicated a low prevalence rate of HCV in the studied population.

Conclusions:

  • The prevalence rate of Hepatitis C virus infection in the general population of Mashhad is below 1%.
  • These findings are critical for informing public health policies and interventions in the region.
  • Continued surveillance is recommended to monitor and manage HCV infection effectively.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...